[EXECUTION VERSION CHINA CORD BLOOD CORPORATION 7% SENIOR CONVERTIBLE NOTE Original Principal Amount: US$50,000,000 Company Holder Principal and Issuance Date and Note Notes Other Notes Registration Rights Agreement FOR VALUE RECEIVED, China Cord Blood Corporation, an exempted company with limited liability incorporated in the Cayman Islands (the “ 1. Rank pari passu 2. Maturity Maturity Date (a) Subject to the] [EXECUTION VERSION REGISTRATION RIGHTS AGREEMENT between CHINA CORD BLOOD CORPORATION and GOLDEN MEDITECH HOLDINGS LIMITED Dated October 3, 2012 TABLE OF CONTENTS Page Section 1 DEFINITIONS 1 Section 2 GENERAL; SECURITIES SUBJECT TO THIS AGREEMENT 5 Section 3 MANDATORY REGISTRATION 5 Section 4 DEMAND REGISTRATION RIGHTS 8 Section 5 INCIDENTAL OR “PIGGY-BACK” REGISTRATION 9 Section 6 UNDERWRITTEN OFFERINGS 9 Section] [China Cord Blood Corporation Announces Completion of $50 Million Convertible Note Financing with Golden Meditech HONG KONG, China, October 3, 2012 China Cord Blood Corporation (NYSE: CO) (“CCBC” or the “Company”), the first and largest cord blood banking operator in China, announced that it has successfully completed the previously announced The board of directors of CCBC has appointed Mr. Yuen]